Spectral Diagnostics

Spectral Diagnostics reports $4.7 million consolidated loss for year ended March 31, 2006

Published in Lab Business Week, July 23rd, 2006

Spectral Diagnostics Inc. (SDI) reported a consolidated loss for the year ended March 31, 2006 of $4.7 million (23 cents per share) compared to a loss in the previous year of $7.4 million (40 cents per share).

Current year results include a one time gain of $2.4 million (12 cents per share) on the sale of the company's rapid cardiac test business in the fourth quarter.

Revenues for the year were $7.3 million, a drop of $2.7 million from last year. Rapid cardiac test sales were $4.3 million compared to $7.1 million in 2005. This decline was attributable to a continuing trend of lower sales volumes and to the sale of the rapid cardiac business...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-07-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database